BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 25861714)

  • 1. New aspects on the pathogenesis of renal disorders related to monoclonal gammopathies.
    Kapoulas S; Raptis V; Papaioannou M
    Nephrol Ther; 2015 Jun; 11(3):135-43. PubMed ID: 25861714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
    Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
    Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA; San-Miguel JF; Mateos MV; Rajkumar SV
    Hematol Oncol Clin North Am; 2014 Oct; 28(5):775-90. PubMed ID: 25212882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Renal involvement in monoclonal gammopathy and multiple myeloma].
    De Sanctis LB; Sestigiani E; Sgarlato V; Fabbrizio B; Santoro A
    G Ital Nefrol; 2010; 27 Suppl 50():S19-33. PubMed ID: 20922692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.
    International Myeloma Working Group
    Br J Haematol; 2003 Jun; 121(5):749-57. PubMed ID: 12780789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal gammopathies of renal significance.
    Gnanasampanthan S; Kousios A
    Clin Med (Lond); 2023 May; 23(3):250-253. PubMed ID: 37236803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant.
    Leung N; Bridoux F; Hutchison CA; Nasr SH; Cockwell P; Fermand JP; Dispenzieri A; Song KW; Kyle RA;
    Blood; 2012 Nov; 120(22):4292-5. PubMed ID: 23047823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal outcome and monoclonal immunoglobulin deposition disease in 289 old patients with blood cell dyscrasias: a single center experience.
    Stratta P; Gravellone L; Cena T; Rossi D; Gaidano G; Fenoglio R; Lazzarich E; Quaglia M; Airoldi A; Bozzola C; Monga G; Valente G; Canavese C; Magnani C
    Crit Rev Oncol Hematol; 2011 Jul; 79(1):31-42. PubMed ID: 20570173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Skin disorders associated with monoclonal gammopathies].
    Houtman CJ; Genders RE; von dem Borne PA; Vermeer MH
    Ned Tijdschr Geneeskd; 2014; 158():A6717. PubMed ID: 24780569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for and diagnosis of monoclonal gammopathy.
    Chong YP; Lim SM; Loh TP; Mollee P; Wijeratne N; Choy KW
    J Clin Pathol; 2023 Nov; 76(11):727-733. PubMed ID: 37604683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ultrastructural basis of renal pathology in monoclonal gammopathies.
    Santostefano M; Zanchelli F; Zaccaria A; Poletti G; Fusaroli M
    J Nephrol; 2005; 18(6):659-75. PubMed ID: 16358223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal gammopathy-associated proliferative glomerulonephritis.
    Sethi S; Rajkumar SV
    Mayo Clin Proc; 2013 Nov; 88(11):1284-93. PubMed ID: 24182705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single monoclonal spike characterized as double monoclonal gammopathy in a patient with multiple myeloma: A rare finding.
    Saijpaul R; Khurana V; Verma R; Kaushik S
    Indian J Pathol Microbiol; 2024; 67(1):192-194. PubMed ID: 38358220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal gammopathy and spurious hypophosphatemia.
    Weisbord SD; Chaudhuri A; Blauth K; DeRubertis FR
    Am J Med Sci; 2003 Feb; 325(2):98-100. PubMed ID: 12589234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of paraproteinaemia.
    Cook L; Macdonald DH
    Postgrad Med J; 2007 Apr; 83(978):217-23. PubMed ID: 17403946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic criteria of multiple myeloma.
    Kyle RA
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):347-58. PubMed ID: 1582977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical abnormalities in multiple myeloma.
    Choo-Kang E; Campbell M
    West Indian Med J; 1991 Dec; 40(4):170-2. PubMed ID: 1785196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal gammopathy: significance and possible causality in renal disease.
    Paueksakon P; Revelo MP; Horn RG; Shappell S; Fogo AB
    Am J Kidney Dis; 2003 Jul; 42(1):87-95. PubMed ID: 12830460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal gammopathies and the kidney.
    Kyle RA
    Annu Rev Med; 1989; 40():53-60. PubMed ID: 2499246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neurologic manifestations of monoclonal gammapathies].
    Uldry PA; Steck AJ; Regli F
    Schweiz Med Wochenschr; 1984 Nov; 114(47):1678-85. PubMed ID: 6096963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.